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Abstract
Background: Trisomy 21 Down syndrome is the most common genetic cause for congenital malformations and
intellectual disability. It is well known that in the outstanding majority of cases the extra chromosome 21 originates
from the mother but only in less than 10 % from the father. The mechanism underlying this striking difference in
parental origin of Trisomy 21 Down syndrome is still unknown. However, it seems likely that the main reason is a
much higher stringency in the elimination of any trisomy 21 cells during fetal testicular than ovarian development.
We have here focussed attention on the paternal gametic output, i.e. the incidence of disomy 21 in spermatozoa.
Results: We have used fluorescence in situ hybridisation (FISH) to determine the copy number of chromosome 21
in spermatozoa from 11 men with normal spermiograms. Due to the well-known risk of false positive and false
negative signals using a single FISH probe, we have applied two chromosome 21q probes, and we have added
a chromosome 18-specific probe to allow differentiation between disomy 21 and diploidy. Analysing a total
number of 2000 spermatozoa per case, we documented an average incidence of disomy 21 at 0.13 %, with a
range of 0.00-0.25 % and a SD of 0.08. There was no indication of diploidy in this cohort of 22,000 sperm.
Conclusion: Numerous previous studies on the incidence of disomy 21 in sperm have been published, using
FISH. As far as we are aware, none of these have applied more than a single chromosome 21-specific probe.
Accepting our mean of 0.13 % of disomy 21, and providing there is no selective fertilisation capability of disomy
21 sperm in relation to the normal, we conclude that around 1 in 800 conceptions is expected to be trisomic
for chromosome 21 of paternal origin. Bearing in mind that the maternal origin likely is at least 10 times more
common, we tentatively propose that around 1 in 80 oocytes in the maternal ovarian reserve may be disomy
21. One reason for this discrepancy may be a more stringent selection against aberrant chromosome numbers during
spermatogenesis than oogenesis. Further work is required to determine the relevant stages of spermatogenesis at
which such a selection may take place.
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Background
Down syndrome is by far the most common genetic rea-
son for congenital malformations and intellectual disabil-
ity in the human population. In a recent survey of 29,256
cases, ascertained during 1989 to 2009 in the UK, where
the diagnosis had been made by the Cytogenetic Labora-
tories, nearly 97 % of all cases were free trisomy 21. The
incidence of live births in the whole cohort of cases was 1
per 1000 [1].
It is well known that the outstanding majority of cases
with a free extra chromosome 21 originate from the
mother, i.e. in over 90 % of cases, and less than 10 % is
paternal. Naturally, much attention has focussed on the
mechanism underlying the maternal origin, in particular
the reason for the so-called maternal age effect, i.e. a
drastic increase in incidence at advanced maternal age.
It is now generally accepted that the majority of cases
are due to a disturbance occurring during the long
meiotic prophase (lasting from mid fetal life until meno-
pause), leading to so-called primary non-disjunction of
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the two chromosomes 21 at the first meiotic division,
taking place just before ovulation (see e.g. Table one in
[2], [3–5]). In sharp contrast, we have concluded that
the majority, if not all cases of T21, having an extra free
chromosome 21, are not caused by any problem in the
first meiotic cell division per se. Instead we suggest that
the crucial factor is the general occurrence of pre-
meiotic/mitotic T21 mosaicism, leading to so-called sec-
ondary meiotic non-disjunction of the oocytes having
three chromosomes 21 [2, 6, 7]. This hypothesis, based
on the occurrence of around 1/200 oogonia showing
T21, has been criticised by Rowsey et al [5], who, using
fluorescence in situ hybridisation (FISH) with a 13/21
centromere probe, could not detect a single T21 oocyte.
They scored a total of 1,206 oocytes at the first meiotic/
Leptotene, stage from seven fetal ovarian samples, i.e. less
than 200 cells per case. It goes without saying that further
work is required to either dismiss or confirm our hypoth-
esis that pre-meiotic T21 mosaicism plays an outstanding
role in the maternal origin of T21 Down syndrome.
By comparison, very little work has been devoted to
the understanding of the paternal origin of T21 Down
syndrome. We have previously investigated the incidence
of T21 in fetal testicular cell nuclei from four male foe-
tuses, following termination of pregnancy for a non-
medical/social reason at gestational age 14-19 weeks.
Using FISH with two chromosome–specific probes, and
analysing at least 2000 premeiotic/mitotic cells per case,
we could not detect a single cell with T21. We tenta-
tively concluded that there is a much more stringent se-
lection against aneuploidy during fetal spermatogenesis
than oogenesis [8]. There is also an indication that a
similar selection against aneuploidy may take place post-
meiotically during spermiogenesis ([9], review in [10]).
Table 1 Analysis of semen samples using FISH with two DNA-probes from chromosome 21, Vysis 21q22 (red) and Cytocell 21qtel (green)
together with a control chromosome 18 probe, Abbot (blue), to allow differentiation between disomy and diploidy (or disomy 21 plus
disomy 18)
No of signals from the two chr 21
DNA probes
1green/1red 2green/2red 2green/1red1 1green/2red1 1green/0red1 0green/1red1 Total no
of cells(normal) (disomy)
Sample and age of the men HP1 1988 (99.4 %) 5 (0.25 %) 3 (0.15 %) 4 (0.2 %) 0 (0.00 %) 0 (0.00 %) 2000
32 y
HP2 1994 (99.7 %) 3 (0.15 %) 0 (0.00 %) 3 (0.15 %) 0 (0.00 %) 0 (0.00 %) 2000
37 y
HP3 1992 (99.6 %) 2 (0.10 %) 2 (0.10 %) 4 (0.2 %) 0 (0.00 %) 0 (0.00 %) 2000
39 y
HP4 1991 (99.55 %) 1 (0.05 %) 4 (0.2 %) 4 (0.2 %) 0 (0.00 %) 0 (0.00 %) 2000
33 y
HP5 1978 (98.9 %) 0 (0.00 %) 3 (0.15 %) 14 (0.7 %) 5 (0.25 %) 0 (0.00 %) 2000
45 y
3486 1991 (99.55 %) 3 (0.15 %) 4 (0.2 %) 2 (0.10 %) 0 (0.00 %) 0 (0.00 %) 2000
28 y
3499 1993 (99.65 %) 4 (0.2 %) 2 (0.10 %) 1 (0.05 %) 0 (0.00 %) 0 (0.00 %) 2000
53 y
3500 1992 (99.6 %) 2 (0.10 %) 2 (0.10 %) 3 (0.15 %) 0 (0.00 %) 1 (0.05 %) 2000
30 y
3501 1986 (99.3 %) 2 (0.10 %) 1 (0.05 %) 9 (0.45 %) 0 (0.00 %) 2 (0.10 %) 2000
42 y
3502 1992 (99.6 %) 5 (0.25 %) 1 (0.05 %) 1 (0.05 %) 1 (0.05 %) 0 (0.00 %) 2000
40 y
3505 1995 (99.75 %) 1 (0.05 %) 0 (0.00 %) 3 (0.15 %) 1 (0.05 %) 0 (0.00 %) 2000
35
Mean 1990 (99.51 %) 2.5 (0.13 %) 2.0 (0.10 %) 4.4 (0.22 %) 0.6 (0.03 %) 0.3 (0.01 %)
SD 4.5 (0.23 %) 1.6 (0.08 %) 1.3 (0.07 %) 3.7 (0.18 %) 1.4 (0.07 %) 0.6 (0.03 %)
1Those spermatozoa showing either 2 green/1 red, 1 green/2 red, 1 green/0 red or 0 green/1 red signals were interpreted as false positives or false negatives,
respectively, and were therefore excluded in the results of true disomy 21
Standard deviation (SD)
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On the other hand, a large number of studies have
been devoted to the analysis of the incidence of disomy
21 in sperm obtained from normal controls. However, as
far as we are aware, all of these studies have used a
single chromosome 21 probe, and bearing in mind the
possibility of false negatives, the raw values obtained
have been multiplied by 2 [10]. We here present the re-
sults of scoring disomy 21 in sperm, obtained from 11
men with normal spermiograms. In order to avoid both
false positives and false negatives [11, 12] we have in this
study used the same two 21q-specific probes as in our
previous investigations of the fetal testicular and ovarian
fetal samples (Vysis 21q and Cytocell 21tel) together
with a control chromosome 18 probe to allow differenti-
ation between disomy 21 and diploidy (or disomy 21
plus disomy 18).
Results and discussion
The average incidence of chromosome 21 disomy in the
sperm samples from this cohort of 11 men was 0.13 %,
with a range of 0.00 %-0.25 %, SD 0.08 (Table 1). On this
score, and provided there is no difference in fertilisation
capability between the normal and the disomy 21 sperm,
we may therefore expect around 1 per 800 conceptions
to be trisomic for chromosome 21 of paternal origin. To
our knowledge this is the first FISH study using two ra-
ther than a single probe for the estimation of the copy
number of chromosome 21, an approach that we used
for the analysis of 2000 spermatozoa per case. Examples
of the FISH images in a normal monosomy 21 in com-
parison to a disomy 21 sperm head are shown in Fig. 1.
There are numerous investigations recording the rate
of disomy 21 in sperm from apparently normal controls,
using a single chromosome 21 probe. Results vary sub-
stantially in estimates of disomy 21 in individual sperm
samples from 0.03-0.37 % [10]. To date it is not known
to what extent this large variation reflects true biological
variation or maybe due to technological problems in the
FISH analysis of chromosome copy number, including in
particular the use of a single chromosome 21-specific
probe [13].
Our results, using two chromosome 21- specific
probes, indicate that the average is in the order of
0.13 %. Interestingly, there are indications that there is
no selection against chromosomally abnormal sperm at
fertilization [14, 15].
By comparison to the large number of studies devoted
to the study of sperm chromosome aneuploidy, there are
so far only a few papers dealing with its mechanism of
origin [8, 16, 14, 10]. The occurrence of disomy 21 in a
sperm sample may in principle be due to mitotic mal-
segregation at prenatal and postnatal development, as
well as by first and second meiotic non-disjunction post
puberty.
To our knowledge there are no adequate counts of
chromosome 21 copy number in pre-meiotic, spermato-
gonial, metaphases from testicular biopsies of adult men.
The information as regards the post-pubertal meiotic
metaphase stages, Metaphase I (MI) and Metaphase II
(MII) is also very limited. No chromosome 21 copy
number changes were found by Uroz et al. [17] or Uroz
and Templado [9] in a total sample of 485 spermatocytes
at the MI stage from five normally fertile men. Likewise,
neither Laurie et al. [18] nor Uroz et al. [17] identified
any chromosome 21 copy number changes in a total of
266 cells at the MII stage from eight men. On the other
hand, analysing 248 MII cells Uroz and Templado [9]
detected one extra chromosome 21 in one MII cell, as
well as one extra 21 chromatid in two out of the from
three men (1.2 %).
In spite of the lack of a statistically significant paternal
age effect [19, 20] it may then be prudent to pay special
LSI 21 (Vysis)
21q22.13-21q22.2
tel 21 (Cytocell) 
D21S1575
a b c
Fig. 1 Examples of fluorescence in situ hybridisation (FISH) results, using two chromosome 21 specific probes (Vysis LSI 21 in red and Cytocell tel
21 in green). a Location of the probes near the end of the long arm of chromosome 21. Reproduced from [7] b A normal spermatozoon showing one
dual chromosome 21-specific signal in combination with one chromosome 18 control probe signal (Vysis CEP18 in pink). c A spermatozoon showing
two dual chromosome 21-specific signals (red and green) together with one chromosome 18 signal, therefore recorded as disomy 21.
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attention to the possibility of positive proliferative selec-
tion, leading to clustering of aberrant cell nuclei [21, 22].
Finally, it would be of added interest to compare the in-
cidence of chromosome 21 copy number changes at the
different stages of spermatogenesis with that in sperm as
well as that in blood samples from the same men (see
previous examples in Table two in [8], [23–25]). These
preliminary data indicate that a combination of somatic
and germinal chromosome 21 mosaicism may be com-
mon among men in the general population.
Conclusion
Based on the results of this, the one and only evaluation
of the incidence of disomy 21 in spermatozoa from men
with normal spermiograms, using two differently coloured
FISH probes, we conclude that in the order of 1 in 800
conceptions is expected to be trisomic for chromosome
21 of paternal origin. Bearing in mind the 10 times higher
likelihood of maternal origin, we further suggest that the
incidence of disomy 21 in oocytes, comprising the mater-
nal ovarian reserve, may be in the order of 1 in 80. The
mechanism(s) underlying this striking difference is not
known but there are indications from the few studies so
far performed that there is a more stringent selection
against aneuploidy during spermatogenesis than during
oogenesis.
Methods
Semen samples were obtained from 11 healthy males with
normal spermiograms, where the couples had been re-
ferred for investigation of infertility, and it had turned out
that the female partners had been diagnosed as infertile.
The samples were anonymised and all procedures per-
formed with informed consent and ethical approval from
the Regional Ethical Committee at Karolinska Institutet,
reference number 03-010.
Semen preparation
Spermatozoa from whole semen (n = 11) were washed
three times in phosphate-buffered saline (PBS) at pH7.2.
After an initial centrifugation of 1 ml of whole semen at
650 x g for 10 min, the supernatants were withdrawn
and the sperm pellets were re-suspended in 2 mL of
PBS. The procedure was repeated twice, and the final
pellets were re-suspended and fixed in methanol/acetic
acid (3:1). The samples were stored at -20 °C until used.
FISH
Microscopy slides for FISH analysis were prepared by
dripping 5 μl of spermatozoa suspension on clean slides,
followed by air drying at room temperature. The slides
were then washed in 2X standard saline citrate (SSC) and
decondensed, using incubation in 4 mM dithiothreitol
(DTT) for 5 min at room temperature. After additional
washing in phosphate-buffered saline (PBS) and dehydra-
tion through a series of alcohol, the slides were left to air-
dry at room temperature. Slides were then denatured in
70 % formamide at 73 °C for 2 min and dehydrated in an
ethanol series at -20 °C.
Two DNA probes, positioned near the end of the long
arm of chromosome 21 and labelled in SpectrumOrange
and SpectrumGreen, respectively, were used (Vysis LSI
21 SpectrumOrange, Cat No: 05 J13-002, Abbot Molecu-
lar Inc, USA and Cytocell, Cat No. LPT21QG/R, Cytocell
Technologies Ltd. UK). A chromosome 18 centromeric
probe, labelled in SpectrumAqua, was added to be able to
differentiate between disomy and diploidy (CEP 18 Spec-
trumAqua Probe (D18Z1), Cat No: 32-131018, Abbot
Molecular Inc, USA). The DNA probes were mixed, dena-
tured for 5 min at 73 °C and added to the slides, followed
by hybridisation and post-hybridisation washing, accord-
ing to the manufacturers’ instructions. After dehydration,
slides were mounted in glycerol, containing 2.3 % DABCO
(1, 4-diazabicyclo-(2, 2, 2) octane) as antifade and DAPI
(4, 6,-diamino-2-phenyl-indole) 0.5 mg/ml for nuclear
counterstaining.
Fluorescent signals were analysed, using a Zeiss Axios-
kop 2 microscope equipped with a cooled CCD camera
(CoolSnap; Photometrics Ltd, USA), controlled by a Power
Macintosh computer. Grey scale images were captured,
pseudo-coloured and merged, using the SmartCapture 2
software (Digital Scientific Ltd, UK).
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